NASDAQ:LABT | Cash Flow Statement | Lakewood-Amedex Biotherapeutics Inc.

Complete source-backed cash-flow history.

Available history
2025-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$3.77M
2026-03-31-$923,291.00-$349,691.00$125,000.00
2025-06-30-$655,943.00
2025-03-31-$539,617.00-$404,089.00$200,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow